According to the "Company Law of the People's Republic of China," "Guidelines for the Governance of Listed Companies," and other relevant laws and regulations, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (hereinafter referred to as "the Company") convened a board meeting on March 27, 2026, to discuss the confirmation of the 2025 compensation for directors and senior management and the compensation plan for 2026.
I. Confirmation of 2025 Compensation for Directors and Senior Management
The compensation situation for the Company's directors and senior management for 2025 is as follows: